Acute Lymphoblastic Leukemia, Pediatric Recruiting Phase 1 / 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03705507International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic LeukaemiaTreatment